Knee Replacement Types for Osteoarthritis
(MP-Persona Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Knee osteoarthritis (OA) is a highly prevalent condition that results in substantial pain and loss of function. The end stage treatment for knee OA is total knee arthroplasty (TKA), a common and safe procedure typically performed for relief of symptoms. However, an increasing number of patients are complaining about their TKA due to altered sensations between their previous joint and the implant. Although several designs have been proposed to improve these outcomes, the knee kinematics after TKA remains different from physiological kinematics. The Medial Pivot TKA design was introduced to closely mimic normal knee kinematics and create the natural feeling of the knee. This study is intended to evaluate the clinical effectiveness and ability to restore knee motion of two TKA devices: the Medial Pivot Persona TKA Zimmer design with the traditional Zimmer Persona Knee-PS. The investigator's hypothesis is that the Medial Pivot design will results in better patient outcomes and restore knee motion at natural parameters.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What makes the Zimmer MP Persona and Zimmer Persona Knee-PS treatment unique for knee replacement in osteoarthritis?
What data supports the effectiveness of the Zimmer MP Persona and Zimmer Persona Knee-PS treatment for knee replacement in osteoarthritis?
Research shows that the Persona knee implant system, which is part of the Zimmer treatment, has good patient-reported outcomes and implant survivorship up to two years after surgery. Additionally, customized posterior-stabilized knee replacements, similar to the Zimmer Persona Knee-PS, have high patient satisfaction and functional outcomes due to their patient-specific design.12678
Who Is on the Research Team?
John Antoniou, MD, PhD
Principal Investigator
Jewish General Hospital
Are You a Good Fit for This Trial?
This trial is for adults aged 18-80 with knee osteoarthritis who need a total knee replacement and can follow the study's procedures. They must understand and consent to the study, but cannot join if they have inflammatory arthritis, severe neurological or cardiovascular conditions, previous failed leg surgeries, severe hip OA, or recent leg trauma.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo total knee arthroplasty (TKA) with either the Medial Pivot Persona TKA Zimmer design or the traditional Zimmer Persona Knee-PS.
Initial Follow-up
Clinical follow-up visits and radiographic assessments are performed to monitor recovery and implant performance.
Extended Follow-up
Participants are monitored for knee kinematics, muscle activation, and clinical outcomes at 1 and 2 years post-operatively.
What Are the Treatments Tested in This Trial?
Interventions
- Zimmer MP Persona
- Zimmer Persona Knee-PS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lady Davis Institute
Lead Sponsor
McGill University
Collaborator
Zimmer Biomet
Industry Sponsor
Dr. Nitin Goyal
Zimmer Biomet
Chief Medical Officer since 2021
MD from Harvard Medical School
Ivan Tornos
Zimmer Biomet
Chief Executive Officer since 2023
MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business
Montreal General Hospital
Collaborator
Jewish General Hospital
Collaborator